Cardiovascular Disease Risk Estimation in Mutation Confirmed Familial Hypercholesterolaemia

被引：0
|
作者：
Ofagbor, E. [1 ]
Wijesinghe, A. [1 ]
Omosilade, M. [1 ]
Ewang-Emukowhate, M. [1 ]
Nair, D. R. [1 ]
机构：
[1] Royal Free London, NHS Fdn Trust, Dept Clin Biochem, London, England
来源：
ATHEROSCLEROSIS PLUS | 2023年 / 54卷
关键词：
D O I：
10.1016/j.athplu.2023.07.009
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：S10 / S11
页数：2
相关论文
共 50 条
  • [1] Cardiovascular risk stratification in familial hypercholesterolaemia
    Sharifi, Mahtab
    Rakhit, Roby D.
    Humphries, Steve E.
    Nair, Devaki
    HEART, 2016, 102 (13) : 1003 - U111
  • [2] Severe Heterozygous Familial Hypercholesterolaemia in the Netherlands: Prevalence and Risk for Cardiovascular Disease
    Besseling, Joost
    Hovingh, Gerard K.
    Hutten, Barbara A.
    Kastelein, John J.
    CIRCULATION, 2013, 128 (22)
  • [3] PREVALENCE OF CARDIOVASCULAR EVENTS IN GENETICALLY CONFIRMED VERSUS UNCONFIRMED FAMILIAL HYPERCHOLESTEROLAEMIA
    Khan, T.
    Breen, J.
    Grocott-Mason, R.
    Barbir, M.
    ATHEROSCLEROSIS, 2020, 315 : E40 - E40
  • [4] Cardiovascular disease in familial hypercholesterolaemia: Influence of low-density lipoprotein receptor mutation type and classic risk factors
    Alonso, R.
    Mata, N.
    Castillo, S.
    Fuentes, F.
    Saenz, P.
    Muniz, O.
    Galiana, J.
    Figueras, R.
    Diaz, J. L.
    Gomez-Enterria, P.
    Mauri, M.
    Piedecausa, M.
    Irigoyen, L.
    Aguado, R.
    Mata, P.
    ATHEROSCLEROSIS, 2008, 200 (02) : 315 - 321
  • [5] Lipoprotein(A) determination and risk of cardiovascular disease in South African patients with familial hypercholesterolaemia
    Scholtz, CL
    Lingenhel, A
    Hillermann, R
    Stander, IA
    Kriek, JA
    Marais, MP
    Odendaal, HJ
    Kraft, HG
    Utermann, G
    Kotze, MJ
    SOUTH AFRICAN MEDICAL JOURNAL, 2000, 90 (04): : 374 - 378
  • [6] Lipoprotein (a) and risk of cardiovascular disease in patients with metabolic syndrome in a population of familial hypercholesterolaemia
    Rana, J. . S.
    Jansen, A. C.
    Zwinderman, A. H.
    Van Aalst-Cohen, E. S.
    Jukema, J. . W.
    Trip, M. D.
    Kastelein, J. . J. . P.
    JOURNAL OF INTERNAL MEDICINE, 2006, 260 (02) : 183 - 185
  • [7] Risk Factors and Modifiers for Cardiovascular Disease Assessment of Patients with Heterozygous Familial Hypercholesterolaemia
    Malone, Richard
    Savage, Sarah
    Crowley, Vivion
    Hennessy, Martina
    O'Connor, Patricia
    Kennedy, Cormac
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (08)
  • [8] Heterozygous familial hypercholesterolaemia in childhood: Cardiovascular risk prevention
    van der Graaf, A.
    Kastelein, J. J. P.
    Wiegman, A.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2009, 32 (06) : 699 - 705
  • [9] Cellular senescence, telomeres, and cardiovascular risk in familial hypercholesterolaemia
    Banach, Maciej
    Penson, Peter E.
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2022, 29 (05) : 718 - 720
  • [10] Risk of cardiovascular disease outcomes in primary care subjects with familial hypercholesterolaemia: A cohort study
    Iyen, Barbara
    Qureshi, Nadeem
    Kai, Joe
    Akyea, Ralph K.
    Leonardi-Bee, Jo
    Roderick, Paul
    Humphries, Steve E.
    Weng, Stephen
    ATHEROSCLEROSIS, 2019, 287 : 8 - 15
12345